Franssen E - Search Results

1

Does aggressive therapy improve survival in suboptimal stage IIIc/IV ovarian cancer? A Canadian-American comparative study.

LoCoco S, Covens A, Carney M, Franssen E, Dogde R, Rosen B, Osborne R, Kerr I, Buckman R, Soper J, et al. LoCoco S, et al. Among authors: franssen e. Gynecol Oncol. 1995 Nov;59(2):194-9. doi: 10.1006/gyno.1995.0007. Gynecol Oncol. 1995. PMID: 7590472

2

Meta-analysis comparing cisplatin total dose intensity and survival.

Ben-David Y, Rosen B, Franssen E, Einarson T, Szyfer I. Ben-David Y, et al. Among authors: franssen e. Gynecol Oncol. 1995 Oct;59(1):93-101. doi: 10.1006/gyno.1995.1273. Gynecol Oncol. 1995. PMID: 7557623

3

A phase II study of leuprolide in advanced/recurrent endometrial cancer.

Covens A, Thomas G, Shaw P, Ackerman I, Osborne R, Lukka H, Carey M, Franssen E, Roche K. Covens A, et al. Among authors: franssen e. Gynecol Oncol. 1997 Jan;64(1):126-9. doi: 10.1006/gyno.1996.4544. Gynecol Oncol. 1997. PMID: 8995560 Clinical Trial.

4

Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.

Grisaru DA, Covens A, Franssen E, Chapman W, Shaw P, Colgan T, Murphy J, DePetrillo D, Lickrish G, Laframboise S, Rosen B. Grisaru DA, et al. Among authors: franssen e. Cancer. 2003 Apr 15;97(8):1904-8. doi: 10.1002/cncr.11269. Cancer. 2003. PMID: 12673716 Free article.

5

Phase I-II study of 5-fluorouracil, leucovorin, doxorubicin, methotrexate, and long-term oral etoposide (FLAME) in unresectable or metastatic gastric cancer.

Bjarnason GA, Cripps C, Goel R, Fine S, Oza AM, Skillings JR, Kerr I, Germond CJ, Moore MJ, Maroun JA, Franssen E, Dulude H. Bjarnason GA, et al. Among authors: franssen e. Am J Clin Oncol. 1998 Dec;21(6):537-42. doi: 10.1097/00000421-199812000-00001. Am J Clin Oncol. 1998. PMID: 9856651 Clinical Trial.

6

Gynecologists' perspectives regarding ovarian cancer.

Fitch MI, Gray RE, Covens A, Thomas G, Franssen E, DePetrillo D, Rosen B. Fitch MI, et al. Among authors: franssen e. Cancer Prev Control. 1999 Feb;3(1):68-76. Cancer Prev Control. 1999. PMID: 10474755

7

Endometrial carcinoma--relative effectiveness of adjuvant irradiation vs therapy reserved for relapse.

Ackerman I, Malone S, Thomas G, Franssen E, Balogh J, Dembo A. Ackerman I, et al. Among authors: franssen e. Gynecol Oncol. 1996 Feb;60(2):177-83. doi: 10.1006/gyno.1996.0022. Gynecol Oncol. 1996. PMID: 8631535

8

A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer.

Thomas G, Dembo A, Ackerman I, Franssen E, Balogh J, Fyles A, Levin W. Thomas G, et al. Among authors: franssen e. Gynecol Oncol. 1998 May;69(2):137-45. doi: 10.1006/gyno.1998.4990. Gynecol Oncol. 1998. PMID: 9600821 Clinical Trial.

9

The role of abdominal-pelvic radiotherapy in the management of uterine papillary serous carcinoma.

Kwon J, Ackerman I, Franssen E. Kwon J, et al. Among authors: franssen e. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1439-45. doi: 10.1016/j.ijrobp.2004.01.044. Int J Radiat Oncol Biol Phys. 2004. PMID: 15275730

10

Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer?

Yamada Y, Ackerman I, Franssen E, MacKenzie RG, Thomas G. Yamada Y, et al. Among authors: franssen e. Int J Radiat Oncol Biol Phys. 1999 Apr 1;44(1):99-104. doi: 10.1016/s0360-3016(98)00507-0. Int J Radiat Oncol Biol Phys. 1999. PMID: 10219801 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters